Vascular endothelial growth factor (VEGF) is an important component of TME and plays an important role in regulating angiogenesis, and to inhibit its overexpression is an important strategy for the treatment of cancer (Frezzetti et al., 2017). This evidence concerns the gene VEGFA and cancer.